Lanraplenib
Lanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.
Product Specifications
CAS Number
1800046-95-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
443.5
Molecular Formula
C23H25N9O
Notes
Research use only, not for human use.
Receptor
SYK
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2108827-01 0.1 mL
APC/Cy7 Linked Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin E (FceRI)
Ask
View Details MBS2108827-02 0.2 mL
APC/Cy7 Linked Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin E (FceRI)
Ask
View Details MBS2108827-03 0.5 mL
APC/Cy7 Linked Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin E (FceRI)
Ask
View Details 
MBS2108827-04 1 mL
APC/Cy7 Linked Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin E (FceRI)
Ask
View Details